Federal Circuit Rules for Merck in Patent Dispute with Teva
The United States Court of Appeals for the Federal Circuit ruled in favor of pharmaceutical company Merck in a patent dispute with Israeli generics maker Teva Pharmaceutical Industries over Merck's Fosamax®...To view the full article, register now.
Already a subscriber? Click here to view full article